A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Purpose: Radiomics is the extraction of multidimensional imaging features, which when correlated with genomics, is termed radiogenomics. However, radiogenomic biological validation is not sufficiently described in the literature. We seek to establish causality between differential gene expression status and MRI-extracted radiomic-features in glioblastoma. Experimental Design: Radiogenomic predictions and validation were done using the Cancer Genome Atlas and Repository of Molecular Brain Neoplasia Data glioblastoma patients (n = 93) and orthotopic xenografts (OX; n = 40). Tumor phenotypes were segmented, and radiomic-features extracted using the developed radiome-sequencing pipeline. Patients and animals were dichotomized on the basis of Periostin (POSTN) expression levels. RNA and protein levels confirmed RNAi-mediated POSTN knockdown in OX. Total RNA of tumor cells isolated from mouse brains (knockdown and control) was used for microarray-based expression profiling. Radiomic-features were utilized to predict POSTN expression status in patient, mouse, and interspecies. Results: Our robust pipeline consists of segmentation, radiomic-feature extraction, feature normalization/selection, and predictive modeling. The combination of skull stripping, brain-tissue focused normalization, and patient-specific normalization are unique to this study, providing comparable cross-platform, cross-institution radiomic features. POSTN expression status was not associated with qualitative or volumetric MRI parameters. Radiomic features significantly predicted POSTN expression status in patients (AUC: 76.56%; sensitivity/specificity: 73.91/78.26%) and OX (AUC: 92.26%; sensitivity/specificity: 92.86%/91.67%). Furthermore, radiomic features in OX were significantly associated with patients with similar POSTN expression levels (AUC: 93.36%; sensitivity/specificity: 82.61%/95.74%; P = 02.021E−15). Conclusions: We determined causality between radiomic texture features and POSTN expression levels in a preclinical model with clinical validation. Our biologically validated radiomic pipeline also showed the potential application for human–mouse matched coclinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
XGBoost: A Scalable Tree Boosting System
Chen, T., & Guestrin, C. (2016) · arXiv · doi:10.48550/arxiv.1603.02754 · Cited by 7,104
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Aerts, H. J. W. L., Velazquez, E. R., Leijenaar, R. T. H., Parmar, C., Grossmann, P., Carvalho, S., Bussink, J., Monshouwer, R., Haibe-Kains, B., Rietveld, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5006 · Cited by 5,132 · cited 2×
“6 captures microscale information hidden within conventional imaging and beyond what is visible to the naked human eye [5-7].”
BackgroundRadiomics: the process and the challenges
Kumar, V., Gu, Y., Basu, S., Berglund, A., Eschrich, S. A., Schabath, M. B., Forster, K., Aerts, H. J. W. L., Dekker, A., Fenstermacher, D., et al. (2012) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2012.06.010 · Cited by 2,258 · cited 1×
“For a method to be translated into clinical practice robustness, generalizability and scalability of the technique are required (45).”
MethodZhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3090 · Cited by 940 · cited 2×
“POSTN, expressed in glioma cells including GSCs and secreted to extracellular matrix in tumormicroenvironment, is involved in invasion and perivascular niche formation, metastasis, and macrophage recruitment (19, 42).”
BackgroundAssessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
Davnall, F., Yip, C. S. P., Ljungqvist, G., Selmi, M., Ng, F., Sanghera, B., Ganeshan, B., Miles, K. A., Cook, G. J., & Goh, V. (2012) · Insights into Imaging · doi:10.1007/s13244-012-0196-6 · Cited by 878
External validation is necessary in prediction research:
Bleeker, S. E., Moll, H. A., Steyerberg, E. W., Donders, A. R. T., Derksen-Lubsen, G., Grobbee, D. E., & Moons, K. G. M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00207-5 · Cited by 710
Nishino, M., Giobbie-Hurder, A., Gargano, M., Suda, M., Ramaiya, N. H., & Hodi, F. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0895 · Cited by 522 · cited 1×
“In fact, all current imaging assessment criteria (such as response evaluation criteria in solid tumors (RECIST), response assessment in neuro-oncology (RANO), immune related RECIST (irRECIST), and immune related response criteria (irRC)) used to evaluate tumor response in the clinical setting and in clinical trials ar…”
BackgroundIdentification of noninvasive imaging surrogates for brain tumor gene-expression modules
Diehn, M., Nardini, C., Wang, D. S., McGovern, S., Jayaraman, M., Liang, Y., Aldape, K., Cha, S., & Kuo, M. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801279105 · Cited by 440
Panth, K. M., Leijenaar, R. T. H., Carvalho, S., Lieuwes, N. G., Yaromina, A., Dubois, L., & Lambin, P. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.06.013 · Cited by 133 · cited 2×
“In a different study using a heterotopic colorectal cancer mouse model, Panth and colleagues found changes in CT imaging features after induced alterations in gene expression and radiation treatment (15).”
Background
Cited by
The Biological Meaning of Radiomic Features
Tomaszewski, M. R., & Gillies, R. J. (2021) · Radiology · doi:10.1148/radiol.2021202553 · Cited by 549
Park, J. E., Park, S. Y., Kim, H. J., & Kim, H. S. (2019) · Korean Journal of Radiology · doi:10.3348/kjr.2018.0070 · Cited by 388
The Biological Meaning of Radiomic Features
Tomaszewski, M. R., & Gillies, R. J. (2021) · Radiology · doi:10.1148/radiol.2021219005 · Cited by 327
Park, J. E., Kim, D., Kim, H. S., Park, S. Y., Kim, J. Y., Cho, S. J., Shin, J. H., & Kim, J. H. (2020) · European Radiology · doi:10.1007/s00330-019-06360-z · Cited by 282
Carré, A., Klausner, G., Edjlali, M., Lerousseau, M., Briend-Diop, J., Sun, R., Ammari, S., Reuzé, S., Alvarez Andres, E., Estienne, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69298-z · Cited by 278
Metadata
- Authors
- Zinn, P. O., Singh, S. K., Kotrotsou, A., Hassan, I., Thomas, G., Luedi, M. M., Elakkad, A., Elshafeey, N., Idris, T., Mosley, J., Gumin, J., Fuller, G. N., de Groot, J. F., Baladandayuthapani, V., Sulman, E. P., Kumar, A. J., Sawaya, R., Lang, F. F., Piwnica-Worms, D., & Colen, R. R.
- Venue
- Clinical Cancer Research
- Published
- 2018-12-13
- Volume
- 24
- Issue
- 24
- Pages
- 6288-6299
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2883650117
- Cited by
- 108
- References
- 10
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-17-3420
- The paper
- Zinn, P. O., Singh, S. K., Kotrotsou, A., Hassan, I., Thomas, G., Luedi, M. M., Elakkad, A., Elshafeey, N., Idris, T., Mosley, J., Gumin, J., Fuller, G. N., de Groot, J. F., Baladandayuthapani, V., Sulman, E. P., Kumar, A. J., Sawaya, R., Lang, F. F., Piwnica-Worms, D., & Colen, R. R. (2018). A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-17-3420
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.